{"schema_version":"secwatch.filing_event.v1","accession":"0001679363-24-000004","form_type":"8-K","ticker":null,"cik":"0001679363","company_name":"Morphic Holding, Inc.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.084463+00:00","generated_at":"2026-06-07T04:43:31.125306+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CEO Praveen Tipirneni returns from medical leave, resumes role effective Jan 2, 2024","bullets":["Dr. Tipirneni resumed day-to-day operational responsibilities as CEO and principal executive officer.","Bruce Rogers stepped down as interim principal executive officer, remains President of Morphic.","Tipirneni will present at the 42nd Annual J.P. Morgan Healthcare Conference on Jan 10, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001679363-24-000004","json":"https://secwatch.observer/filing/0001679363-24-000004.json","markdown":"https://secwatch.observer/filing/0001679363-24-000004.md","text":"https://secwatch.observer/filing/0001679363-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/morf-20240102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:43:31.125306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42fe1d269b","claim":"Bruce N. Rogers changed role as interim principal executive officer at Morphic Holding, Inc..","evidence_excerpt":"Bruce N. Rogers, Ph.D., the Company’s President, is no longer the Company’s interim principal executive officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"is no longer"},{"label":"Role","value":"interim principal executive officer"}],"fact_type":"executive_change"},{"claim_id":"fa15128945","claim":"Praveen Tipirneni changed role as Chief Executive Officer at Morphic Holding, Inc..","evidence_excerpt":"Effective as of January 2, 2024, Dr. Tipirneni has resumed his day-to-day operational responsibilities at the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resumed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}